Inmunohistochemical expression of p53, Bcl-2, COX-2, C-erb-B2, EPO-R, β-catenin, and E-cadherin in non tumoral gastric mucous membrane

European Journal of Histochemistry

Volumn 50, Issue 4, 2006, Pages 285-292

  Sereno, Maria ^a   Garcia Cabezas M A ^a   De Castro, J ^a   Cejas, P ^a   Casado Saenz, E ^a   Belda Iniesta, C ^a   Barriuso Feijoo, J ^a   Larrauri, J ^a   Nistal, M ^a   Gonzalez Baron, M ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Inmunohistochemical expression; Mucous membrane; Non tumoral

Indexed keywords

BETA CATENIN; CELL ADHESION MOLECULE; CYCLOOXYGENASE 2 INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN BCL 2; PROTEIN P53; UVOMORULIN; BIOLOGICAL MARKER; CADHERIN; CTNNB1 PROTEIN, HUMAN; CYCLOOXYGENASE 2; ERYTHROPOIETIN RECEPTOR; MEMBRANE PROTEIN; PROTEIN; PTGS2 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL CYCLE REGULATION; CLINICAL ARTICLE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; STOMACH ADENOCARCINOMA; STOMACH MUCOSA; HISTOLOGY; METABOLISM; MIDDLE AGED;

BETA CATENIN; BIOLOGICAL MARKERS; CADHERINS; CYCLOOXYGENASE 2; FEMALE; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, ERBB-2; RECEPTORS, ERYTHROPOIETIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33847790537     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Barrett C, Magee H, O'toole D, Daly S, Jeffers M. Amplification of the HER-2 gene in breast cancers testing 2+ weak positive by HercepTestTM immunohistochemistry: false positive or false negative IHC? J Clin Pathol 2006(Epub ahead of print).
2. Cheng XX, Wang ZC, Chen XY, Sun Y, Kong QY, Liu J, et al. Frequent loss of membranous E-cadherin in gastric cancers: A cross-talk with Wnt in determining the fate of beta-catenin Clin Exp Metastasis 2005;22:85-93.
3. Chailler P, Menard D. Establishment of human gastric epithelial (HGE) cell lines exhibiting barrier function, progenitor, and prezymogenic characteristics. J Cell Physiol 2005;202:263-74
4. Hanby AM, Poulsom R, Palyford RJ, Wright NA. The mucous neck cell in the human gastric corpus:a distinctive, functional ell lineage. J Pathol 1999;187:331-7
5. Honjo S, Kase S, Osaki M, Ardyanto TD, Kaibara N, Ito H. Cyclo-oxygenase-2 expression in human gastric tubular adenomas and carcinomas; correlation with intratumoral microvessel density and apoptotic index. Anticancer Res 2004;24:1439-44.
6. Hull MA, Thomson JL, Hawkey CJ. Expression of cyclooxigenase 1 and 2 by human gastric endothelial cells. Gut 1999;45:529-36.
7. Koga T, Shibahara K, Kabashima A, Sumiyoshi Y, Kimura Y, Takahashi I, et al. Overexpression of cyclooxygenase-2 and tumor angiogenesis in human gastric cancer. Hepatogastroenterology 2004;51:1626-30.
8. Kopp R, Diebold J, Dreier I, Cramer C, Glas J, Baretton G, et al. (2005). Prognostic relevance of p53 and bcl-2 immunoreactivity for early invasive pT1/pT2 gastric carcinomas: indicators for limited gastric resections? Surg Endosc. 21; [Epub ahead of print]
9. Krajewski S, Krajewska M, Shabaik A, Wang HG, Irie S, Fong L, et al. Inmunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res 1994; 54:5501-7
10. Krishnadath KK, van Blankenstein M, Tilanus HW. Prognostic value of p53 in Barrett's oesophagus. Eur J Gastroenterol Hepatol 1995;7:81-4.
11. Leung WK, To KF, Go MY, Chan KK, Chan FK, Ng EK, et al. Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma. Int J Oncol 2003; 23:1317-22.
12. Liu J, Yu HG, Yu JP, Wang XL, Zhou XD, Luo HS. Overexpression of cyclooxygenase-2 in gastric cancer correlates with the high abundance of vascular endothelial growth factor-C and lymphatic metastasis. Med Oncol 2005;22:389-98.
13. Mawn K. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol 2002;8:987-93.
14. Mizuno M, Okayama N, Kasugai K, Yoshida T, Miyata M, Nitta M, et al. Acid stimulates E-cadherin surface expression o gastric epitheilial cells to stabilize barrier functions via influx of calcium. Eur J Gastroenterol Hepatol 2001;13:127-36.
15. Nagashima F, Boku N, Ohtsu A, Yoshida S, Hasebe T, Ochiai A, et al. Biological Markers as a Predictor for Response and Prognosis of Unresectable Gastric Cancer Patients Treated with Irinotecan and Cisplatin. Jpn J Clin Oncol 2005;22;5:23-29.
16. Nakamura E, Sugihara H, Bamba M, Hattori T. Dynamic alteration of the E-cadherin/catenin complex during cell differentiation and invasion of undifferentiated-type gastric carcinomas. J Pathol 2005;205:349-58.
17. Nakopoulou L, Mylona E, Papadaki I, Kapranou A, Giannopoulou I, Markaki S. Overexpression of cyclooxygenase-2 is associated with a favorable prognostic phenotype in breast carcinoma. Pathobiology 2005;72:241-9.
18. Owen D. Stomach. In: Histology for Pathologists. 2nd ed. Sternberg SS. Ed Lippincott . New York 1997; pp 481-95.
19. Ohgushi M, Kuroki S, Fukamachi H, O'Reilly LA, Kuida K, Strasser A, et al. Transforming growth factor beta-dependent sequential activation of smad, Bim, and caspase 9 mediates physiological apoptosis in gastric epithelial cells. Mol Cell Biol 1995;25:10017-28.
20. Ribatti D, Marzullo A, Nico B, Crivellato E, Ria R, Vacca A. Erythropoietin as an angiogenic factor in gastric carcinoma. Histopathology 2003;42:246-50.
21. Saegusa M, Takano Y, Okayasu I. Bcl-2 expression and its association with cell kinetics in human gastric carcinomas and intestinal metaplasia. J Cancer Res Clin Oncol 1995;121:357-63.
22. Sasaki R. Pleiotropic functions of erythropoietin Intern Med 2003:42:142-9.
23. Yamashita H, Toyama T, Nishio M, Ando Y, Hamaguchi M, Zhang Z, et al. p53 protein accumulation predicts resistance to endocrine therapy and decreased post-relapse survival in metastatic breast cancer. Breast Cancer Res 2006; 25;8:R48 [Epub ahead of print]
24. Yasui W, Oue N, Aung PP, Matsumura S, Shutoh M, Nakayama H. Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 2005;8:86-94.
25. Wallace JL, de Lima OM Jr, Fiorucci S. Lipoxins in gastric mucosal health and disease. Prostaglandins Leukot Essen Fatty Acids 2005;73:251-5.
26. Wang BC, Guo CQ, Sun C, Sun QL, Liu GY, Li DG. Mechanism and clinical significance of cyclooxygenase-2 expression in gastric cancer. World J Gastroenterol 2005;11:3240-4.
27. Zafirellis K, Karameris A, Milingos N, Androulakis G. Molecular markers in gastric cancer: can p53 and bcl-2 protein expressions be used as prognostic factors? Anticancer Res 2005; 25:3629-36.